Strategic Partnerships CCG has a strong academic presence with MOE and PSILO used in over 600 universities worldwide and maintains support offices across North America, Europe and Asia. This creates opportunities for educational licensing, research collaborations, and bundled solutions with academic consortia and training programs.

Integrated Life Sciences CCG offers an integrated software suite (MOE for modeling and design and PSILO for structural data management) that aligns with pharma, biotech and academic R&D workflows, suggesting upsell potential to expand from visualization tools into full CAMD/structural data platforms for larger customers.

Recent Growth Acquisition of Discngine SAS in 2022 and ongoing participation in industry events signals expansion and integration opportunities. This could open cross-sell paths to Discngine customers and leverage expanded product capabilities in life sciences modeling and data management.

Cloud and Infra Readiness CCG's tech stack includes AWS, Google Workspace and modern cloud-based platforms, indicating readiness for scalable deployments, managed services, and enterprise-grade security features that can appeal to mid-to-large pharma and academic institutions seeking compliant cloud solutions.

Revenue Growth Potential With reported revenue in the $10M-$25M range and a model that targets both industry and academia, there is potential to broaden enterprise licenses, expand international sales, and offer tiered packages or annual maintenance contracts to increase customer lifetime value.